SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-040768
Filing Date
2021-10-20
Accepted
2021-10-20 16:33:24
Documents
2
Period of Report
2021-10-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1603
2 EX-24 DOCUMENT attachment1.htm EX-24 4625
  Complete submission text file 0000899243-21-040768.txt   7786
Mailing Address C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address
AHMED NADIM (Reporting) CIK: 0001731193 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39856 | Film No.: 211334559

Mailing Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142 617-410-4650
Cullinan Oncology, Inc. (Issuer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)